Trial Profile
INFLUENCE OF ROSUVASTATIN ON THE BLOOD PRESSURE LOWERING EFFECT OF TELMISARTAN IN HEALTHY KOREANS.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2014
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Telmisartan
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia
- Focus Pharmacodynamics
- 01 Apr 2014 New trial record
- 18 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.